Cosmos Health Inc. (COSM) |
|
3.01 -0.025 (-0.82%)
|
03-22 12:28 |
|
Open: |
3.04 |
Pre. Close: |
3.035 |
|
High:
|
3.09 |
Low:
|
2.9776 |
|
Volume:
|
192,172 |
Market Cap:
|
34(M) |
|
|
|
Technical analysis |
as of: 2023-03-22 12:15:36 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 4.87 One year: 5.78 |
| Support: |
Support1: 2.91 Support2: 2.42 |
| Resistance: |
Resistance1: 4.17 Resistance2: 4.94 |
| Pivot: |
3.64  |
| Moving Average: |
MA(5): 3.25 MA(20): 3.64
MA(100): 3.36  MA(250): 1.73 |
| MACD: |
MACD(12,26): -0.4 Signal(9): -0.4 |
| Stochastic oscillator: |
%K(14,3): 6.3 %D(3): 12.7 |
| RSI: |
RSI(14): 36.1 |
| 52-week: |
High: 23.84 Low: 0.06 |
| Average Vol(K): |
3-Month: 3,986 (K) 10-Days: 605 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ COSM ] has closed above bottom band by 9.0%. Bollinger Bands are 68% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 20 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
3.43 - 3.47 |
3.47 - 3.49 |
|
Low:
|
2.95 - 2.99 |
2.99 - 3.01 |
|
Close:
|
2.99 - 3.05 |
3.05 - 3.09 |
|
Company Description |
|
Cosmos Health Inc. operates as a vertically integrated pharmaceutical company. It offers a proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, health care and baby products, medical devices, and other products through its distribution channels and an ecommerce marketplace. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes, as well as has distribution centers in Greece and the United Kingdom; and operates a warehousing facility. It serves wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois. |
Headline News |
Fri, 17 Mar 2023
Cosmos Health Inc. Enters into a Definitive Agreement to Acquire ... - AccessWire
Tue, 07 Mar 2023
Cosmos Health Enters into a Material Definitive Agreement with Cana Laboratories - Yahoo Finance
Fri, 03 Mar 2023
Should You Hold Cosmos Health Inc (COSM) Stock Friday Morning? - InvestorsObserver
Mon, 27 Feb 2023
Healthcare Stocks on the Move Monday: CFRX, MLEC, SERA, UPH, RETA, APGN, GNPX, COSM - InvestorsObserver
Mon, 27 Feb 2023
Is Cosmos Health Inc (COSM) Stock a Bad Value? - InvestorsObserver
Tue, 21 Feb 2023
Premarket Mover: Cosmos Health Inc (COSM) Down 2.95% - InvestorsObserver
|
Financial Analysis |
| Price to Book Value: |
Neutral |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Neutral |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Drug Manufacturers—Specialty & Generic |
| Shares Out. |
11 (M) |
| Shares Float |
3 (M) |
|
% Held by Insiders
|
16.7 (%) |
|
% Held by Institutions
|
1.5 (%) |
|
Shares Short
|
605 (K) |
|
Shares Short P.Month
|
993 (K) |
Stock Financials |
|
EPS
|
-39.3 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
3.3 |
|
Profit Margin (%)
|
-8.3 |
|
Operating Margin (%)
|
-1.3 |
|
Return on Assets (ttm)
|
-1 |
|
Return on Equity (ttm)
|
-91.5 |
|
Qtrly Rev. Growth
|
-11.7 |
|
Gross Profit (p.s.)
|
0.78 |
|
Sales Per Share
|
5.13 |
|
EBITDA (p.s.)
|
-0.03 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-6 (M) |
|
Levered Free Cash Flow
|
5 (M) |
Stock Valuations |
|
PE Ratio
|
-0.08 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
0.9 |
|
Price to Sales
|
0.58 |
|
Price to Cash Flow
|
-5.22 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
